← Back to Search

Laser Therapy

Fractional CO2 Laser for the Treatment of Lichen Planus Pigmentosus

N/A
Waitlist Available
Led By Heather Goff, MD, MPH
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks post treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a special laser treatment for people with a chronic skin condition called Lichen Planus Pigmentosus. The laser creates tiny injuries in the skin to help it heal and look better. The study aims to see if this treatment is safe and effective for these patients.

Eligible Conditions
  • Lichen Planus Pigmentosus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improvement in dyspigmentation at 12 weeks post treatment
Improvement in dyspigmentation at 24 weeks post treatment
Secondary study objectives
Overall Subject Satisfaction assessed at 12 weeks post treatment
Overall Subject Satisfaction assessed at 24 weeks post treatment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment (CO2 fractional laser) armExperimental Treatment1 Intervention
CO2 fractional laser will be used to treat dyspigmentation in lichen planus pigmentosus in one half along sagittal midline section in each subject.
Group II: No treatment (Control) armActive Control1 Intervention
One half along sagittal midline section in each subject will not receive the CO2 fractional laser treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CO2 fractional laser
2019
Completed Phase 2
~30

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,086 Previous Clinical Trials
1,058,662 Total Patients Enrolled
Heather Goff, MD, MPHPrincipal InvestigatorUT Southwestern Medical Center
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top